National Health Act 1953 Declaration under subsection 85(2AA) (No. PB 15 of 1997) (Cth)

COMMONWEALTH OF AUSTRALIA

National Health Act 1953

PHARMACEUTICAL BENEFITS

DECLARATION UNDER SUBSECTION 85 (2AA)

No. PB 15 of 1997

I, DAVID TREVOR GRAHAM, Assistant Secretary, Pharmaceutical Benefits Branch, Department of Health and Family Services and Delegate of the Minister for Health and Family Services, having in accordance with subsection 85 (2AB) of the National Health Act 1953 obtained the advice of the Pharmaceutical Benefits Advisory Committee, pursuant to subsection 85 (2AA) of the National Health Act 1953, hereby make the following Declaration:

1. This Declaration shall come into operation on 1 November 1997.

1. The drugs and medicinal preparations specified in the Schedule to this Declaration shall cease to be drugs and medicinal preparations to which Part VII of the National Health Act 1953 applies.

THE SCHEDULE

Alprenolol Hydrochloride

Aluminium Hydroxide, Dried

Amorolfine Hydrochloride

Clofibrate

Fluphenazine Hydrochloride

Hyoscyamine Hydrobromide with Atropine Sulfate and Hyoscine Hydrobromide

Hyoscyamine Sulfate with Atropine Sulfate and Hyoscine Hydrobromide

Methyclothiazide

Methyl Salicylate

Metolazone

Promethazine Theoclate

Terbinafine Hydrochloride

Arachis Oil B.P.

Beeswax, White B.P.

Borax B.P.

Calamine B.P.

Camphor Spirit, Compound A.P.F.

Cetomacrogol Emulsifying Wax B.P.

Cetrimide B.P.

Emulsifying Wax B.P.

Ichthammol B.P.

Lobelia Tincture, Ethereal B.P.C. 1973

Methyl Salicylate B.P.

Methyl Salicylate Ointment, Compound A.P.F. 1934

Soap, Soft B.P.

Stramonium Tincture B.P. 1980

Tolu Syrup B.P.

Turpentine Liniment B.P.

Turpentine Oil B.P.

_____________________________________________________________________

Dated this 13^th day of October 1997.

D. GRAHAM

Assistant Secretary

Pharmaceutical Benefits Branch

Department of Health and Family Services

Delegate of the Minister for Health and Family Services